Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 3/20 | 0.71 |
| ▸ | TNKS2 | Q9H2K2 | 3/20 | 0.71 |
| ▸ | PARP1 | P09874 | 2/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.71 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.71 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.70 |
| ▸ | TP53 | P04637 | 2/20 | 0.70 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.70 |
| ▸ | IP6K2 | Q9UHH9 | 2/20 | 0.70 |
| ▸ | KDM1A | O60341 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.70 |
| ▸ | XDH | P47989 | 1/20 | 0.70 |
| ▸ | IPMK | Q8NFU5 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30960382 | 1.00 | TNKS (0.71) | TNKSTNKS2PARP1ALOX5POLH | |
| SCHEMBL4400168 | 0.91 | FYN (0.81) | TNKSTNKS2PARP1ALOX5POLH | |
| SCHEMBL9663466 | 0.90 | CSNK2A2 (0.81) | TNKSTNKS2PARP1ALOX5POLH | |
| SCHEMBL29435863 | 0.90 | CSNK2A2 (0.81) | TNKSTNKS2CYP3A4MEN1CYP2C9 | |
| SCHEMBL29435862 | 0.90 | CSNK2A2 (0.81) | TNKSTNKS2PARP1ALOX5POLH | |
| SCHEMBL29929667 | 0.90 | CSNK2A2 (0.81) | TNKSTNKS2PARP1ALOX5POLH | |
| SCHEMBL26117897 | 0.90 | CSNK2A2 (0.81) | TNKSTNKS2CYP3A4MEN1CYP2C9 | |
| SCHEMBL8934505 | 0.87 | CYP1A1 (0.69) | CYP3A4MEN1CYP2C9KMT2ACYP2C19 | |
| SCHEMBL5320080 | 0.86 | KDM4E (0.81) | TNKSTNKS2PARP1ALOX5POLH | |
| SCHEMBL8934484 | 0.84 | CSNK2A2 (0.60) | TNKSTNKS2PARP1ALOX5POLH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9386787-B2 | Preparations for oral consumption | SYMRISE AG (DE) | 2016-07-12 | — | — | US | disclosed |
| US-20140134114-A1 | PREPARATIONS FOR ORAL CONSUMPTION | SYMRISE AG (DE) | 2014-05-15 | — | — | US | disclosed |
| EP-2386211-A1 | Use of rubusoside to reduce or suppress particular unpleasant taste sensations | Symrise AG (DE) | 2011-11-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140134114-A1 | PREPARATIONS FOR ORAL CONSUMPTION | TAS1R1, TAS2R16, TAS2R1 | TNKS 4790/4885TNKS2 4867/4885PARP1 3643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.